| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |